Company Filing History:
Years Active: 2010-2013
Title: Thomas Jack Newby: Innovator in Feline Vaccine Development
Introduction
Thomas Jack Newby is a notable inventor based in Bennet, NE (US). He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for feline diseases. With a total of 2 patents, his work focuses on innovative methods for immunizing cats against various viral infections.
Latest Patents
Newby's latest patents include groundbreaking methods of vaccine administration and the development of new feline caliciviruses. One of his inventions relates to a vaccine composition against feline calicivirus (CFV) infection. This composition comprises a capsid protein of Feline calicivirus-49 (CFV-49), a pharmaceutical accepted carrier, and optionally an adjuvant. Additionally, he has developed a vaccine for immunizing cats against feline viruses, which includes a nucleic acid clone that encodes the capsid protein of the isolated feline calicivirus. His inventions also describe methods for identifying feline calicivirus useful for producing vaccine compositions and diagnosing infected cats.
Career Highlights
Throughout his career, Thomas Jack Newby has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Zoetis LLC. His experience in these organizations has contributed to his expertise in vaccine development and veterinary medicine.
Collaborations
Newby has collaborated with notable professionals in his field, including David E Lowery and Sing Rong. These partnerships have likely enhanced his research and development efforts in creating effective vaccines for feline diseases.
Conclusion
Thomas Jack Newby is a distinguished inventor whose work in feline vaccine development has made a significant impact on veterinary medicine. His innovative approaches and collaborations continue to advance the field, providing essential solutions for immunizing cats against viral infections.